Connect with us

Company News

Bruker announces first quarter 2021 preliminary revenue

Bruker Corporation today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 – $554 million, representing reported revenue growth of approximately 30% to 31%, compared to the first quarter of 2020. Adjusting for the impact of foreign currency translation and acquisitions, Bruker estimates non-GAAP organic revenue growth in the first quarter of 2021 of approximately 22% to 23% year-over-year. This compares favorably to the Company’s earlier outlook for greater than 15% organic growth for the first quarter.

Strong revenue performance in the first quarter 2021 was driven by double-digit organic year-over-year revenue growth across all three Bruker Scientific Instrument groups, and it included two GHz-class NMR systems.

Bruker expects to report its first quarter 2021 financial results before market opening on Wednesday, May 5, 2021. Business Wire

Copyright © 2024 Medical Buyer

error: Content is protected !!